Results and patterns of failure in patients treated with adjuvant combined chemoradiation therapy for resected pancreatic adenocarcinoma

Cancer

Volumn 115, Issue 16, 2009, Pages 3640-3650

  Hattangadi, Jona A ^a,b   Hong, Theodore S ^b   Yeap, Beow Y ^b   Mamon, Harvey J ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

Adjuvant therapy; Chemoradiation; Gemcitabine; Pancreatic cancer; Patterns of failure

Indexed keywords

CAPECITABINE; FLUOROURACIL; FOLINIC ACID; GEMCITABINE; OXALIPLATIN;

ADULT; AGED; ARTICLE; CANCER ADJUVANT THERAPY; CANCER LOCALIZATION; CANCER RADIOTHERAPY; CONTINUOUS INFUSION; DISEASE FREE INTERVAL; FEMALE; HUMAN; KAPLAN MEIER METHOD; LIVER METASTASIS; LYMPH NODE METASTASIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; PANCREAS ADENOCARCINOMA; PANCREAS RESECTION; PANCREATICODUODENECTOMY; PERITONEUM METASTASIS; POSTOPERATIVE CARE; PRIORITY JOURNAL; PROGNOSIS; RETROSPECTIVE STUDY; TREATMENT FAILURE;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; CHEMOTHERAPY, ADJUVANT; COMBINED MODALITY THERAPY; FEMALE; FLUOROURACIL; HUMANS; MALE; MIDDLE AGED; PANCREATIC NEOPLASMS; RADIOTHERAPY, ADJUVANT; SURVIVAL ANALYSIS; TREATMENT FAILURE;

EID: 68549123555     PISSN: 0008543X     EISSN: 10970142     Source Type: Journal    
DOI: 10.1002/cncr.24410     Document Type: Article

References (26)

1. Kalser MH, Ellenberg SS. Pancreatic cancer. Adjuvant combined radiation and chemotherapy following curative resection. Arch Surg. 1985;120:899-903.
2. [No authors listed] Further evidence of effective adjuvant combined radiation and chemotherapy following curative resection of pancreatic cancer. Gastrointestinal Tumor Study Group. Cancer. 1987;59:2006-2010.
3. Klinkenbijl JH, Jeekel J, Sahmoud T, et al. Adjuvant radiotherapy and 5-fluorouracil after curative resection of cancer of the pancreas and periampullary region: phase III trial of the EORTC Gastrointestinal Tract Cancer Cooperative Group. Ann Surg. 1999;230:776-782; discussion 782-774.
4. Abrams RA, Lillemoe KD, Piantadosi S. Continuing controversy over adjuvant therapy of pancreatic cancer. Lancet. 2001;358:1565-1566.
5. Neoptolemos JP, Dunn JA, Stocken DD, et al. Adjuvant chemoradiotherapy and chemotherapy in resectable pancreatic cancer: a randomised controlled trial. Lancet. 2001;358:1576-1585.
6. Neoptolemos JP, Stocken DD, Friess H, et al. A randomized trial of chemoradiotherapy and chemotherapy after resection of pancreatic cancer. N Engl J Med. 2004;350:1200-1210.
7. Oya N. Chemoradiotherapy for pancreatic cancer: current status and perspectives. Int J Clin Oncol. 2004;9:451-457.
8. Koshy MC, Landry JC, Cavanaugh SX, et al. A challenge to the therapeutic nihilism of ESPAC-1. Int J Radiat Oncol Biol Phys. 2005;61:965-966.
9. Pisters PW, Wolff RA, Crane CH, Evans DB. Combined-modality treatment for operable pancreatic adenocarcinoma. Oncology (Williston Park). 2005;19:393-404, 409; discussion 409-410, 412-416.
10. Spitz FR, Abbruzzese JL, Lee JE, et al. Preoperative and postoperative chemoradiation strategies in patients treated with pancreaticoduodenectomy for adenocarcinoma of the pancreas. J Clin Oncol. 1997;15:928-937.
11. Mehta VK, Fisher GA, Ford JM, et al. Adjuvant radiotherapy and concomitant 5-fluorouracil by protracted venous infusion for resected pancreatic cancer. Int J Radiat Oncol Biol Phys. 2000;48:1483-1487.
12. Oettle H, Post S, Neuhaus P, et al. Adjuvant chemotherapy with gemcitabine vs observation in patients undergoing curative-intent resection of pancreatic cancer: a randomized controlled trial. JAMA. 2007;297:267-277.
13. Neuhaus P, Oettle H, Post, S, et al. CONKO-001: final results of the randomized, prospective, multicenter phase III trial of adjuvant chemotherapy with gemcitabine versus observation in patients with resected pancreatic cancer [abstract]. J Clin Oncol. 2008;26(15S). Abstract 4514.
14. Regine WF, Winter KA, Abrams RA, et al. Fluorouracil versus gemcitabine chemotherapy before and after fluorouracil-based chemoradiation following resection of pancreatic adenocarcinoma: a randomized controlled trial. JAMA. 2008;299:1019-1026.
15. Abrams RA, Winter KA, Regine WF, et al. Correlation of RTOG 9704 (adjuvant therapy [rx] of pancreatic adenocarcinoma [pan ca]) radiation therapy quality assurance scores (RTQASc) with survival (S) [abstract]. J Clin Oncol. 2007;25(18S). Abstract 4523.
16. Social Security Death Index. Accessed via rootsweb.com. Available at: http://ssdi.rootsweb.com/. Accessed January 25, 2008.
17. Consumer Health Ratings. Massachusetts Health Care Quality and Cost Information: Pancreatectomy, 2005. Available at: http://www. consumerhealthratings.com/index.php?action=showSubCats&cat-id=71. Accessed January 17, 2008.
18. Sobin LH, Wittekind C, eds. TNM Classification of Malignant Tumors. 5th ed. New York, NY: John Wiley & Sons, Inc.; 1997.
19. Greene FL, Page DL, Fleming ID, et al, eds. AJCC Staging Manual. 6th ed. New York, NY: Springer-Verlag; 2002.
20. Chu QD, Khushalani N, Javle MM, Douglass HOJ, Gibbs JF. Should adjuvant therapy remain the standard of care for patients with resected adenocarcinoma of the pancreas? Ann Surg Oncol. 2003;10:539-545.
21. Hsu CC, Herman JM, Corsini MM, et al. Benefit of adjuvant chemoradiation therapy for pancreatic adenocarcinoma: the Johns Hopkins Hospital-Mayo Clinic collaborative study of 1,045 patients [abstract]. Paper presented at: 2008 Gastrointestinal Cancers Symposium; January 25-27, 2008; Orlando, Fla. Abstract 124. Available at: http://www.asco.org/ASCO/Abstracts+%26+Virtual+Meeting/ Abstracts?&vmview=abst-detail-view&confID=53&abstractID=10067. Accessed May 12, 2008.
22. Herman JM, Swartz MJ, Hsu CC, et al. Analysis of fluorouracil-based adjuvant chemotherapy and radiation after pancreaticoduodenectomy for ductal adenocarcinoma of the pancreas: results of a large, prospectively collected database at the Johns Hopkins Hospital. J Clin Oncol. 2008;26:3503-3510.
23. Abrams RA, Grochow LB, Chakravarthy A, et al. Intensified adjuvant therapy for pancreatic and periampullary adenocarcinoma: survival results and observations regarding patterns of failure, radiotherapy dose and CA19-9 levels. Int J Radiat Oncol Biol Phys. 1999;44:1039-1046.
24. Foo ML, Gunderson LL, Nagorney DM, et al. Patterns of failure in grossly resected pancreatic ductal adenocarcinoma treated with adjuvant irradiation +/- 5 fluorouracil. Int J Radiat Oncol Biol Phys. 1993;26:483-489.
25. Foo ML, Gunderson LL. Adjuvant postoperative radiation therapy +/- 5-FU in resected carcinoma of the pancreas. Hepatogastroenterology. 1998;45:613-623.
26. Paulino AC. Resected pancreatic cancer treated with adjuvant radiotherapy with or without 5-fluorouracil: treatment results and patterns of failure. Am J Clin Oncol. 1999;22:489-494.